Waddell & Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Sell |
719
-70
| -9% | -$27.2K | 0.03% | 181 |
|
|
2025
Q1 | $343K | Hold |
789
| – | – | 0.04% | 111 |
|
|
2024
Q4 | $291K | Hold |
789
| – | – | 0.03% | 125 |
|
|
2024
Q3 | $410K | Hold |
789
| – | – | 0.05% | 92 |
|
|
2024
Q2 | $428K | Hold |
789
| – | – | 0.06% | 83 |
|
|
2024
Q1 | $409K | Hold |
789
| – | – | 0.06% | 83 |
|
|
2023
Q4 | $372K | Hold |
789
| – | – | 0.05% | 94 |
|
|
2023
Q3 | $344K | Hold |
789
| – | – | 0.05% | 112 |
|
|
2023
Q2 | $351K | Sell |
789
-4
| -0.5% | -$1.78K | 0.05% | 108 |
|
|
2023
Q1 | $365K | Hold |
793
| – | – | 0.06% | 97 |
|
|
2022
Q4 | $407K | Buy |
793
+239
| +43% | +$123K | 0.07% | 86 |
|
|
2022
Q3 | $252K | Buy |
+554
| New | +$252K | 0.05% | 111 |
|
|
2022
Q2 | – | Sell |
-554
| Closed | -$272K | – | 146 |
|
|
2022
Q1 | $272K | Hold |
554
| – | – | 0.04% | 106 |
|
|
2021
Q4 | $257K | Hold |
554
| – | – | 0.04% | 105 |
|
|
2021
Q3 | $207K | Hold |
554
| – | – | 0.04% | 108 |
|
|
2021
Q2 | $212 | Buy |
+554
| New | +$212 | 0.03% | 115 |
|